Bleeding outcomes were similar across groups.<h4>Conclusion</h4>Clopidogrel is less effective in patients with CYP2C19 LoF genotype and cardiovascular disease, minor stroke, or TIA. The gene discussed is CYP2C19; the disease is transient ischemic attack.